Zoster Eye Disease Study
Trial ID or NCT#
NCT03134196
Status
NOT RECRUITING
Purpose
This is a multi-center, randomized, double-masked, placebo-controlled clinical trial of suppressive valacyclovir for one year in immunocompetent study participants with an episode of dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis due to Herpes Zoster Ophthalmicus (HZO) in the year prior to enrollment.
Official Title
Long-term Suppressive Valacyclovir Treatment for Herpes Zoster Ophthalmicus
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Investigator(s)
Charles C. Lin, MD
Cornea specialist,
Cataract specialist
Clinical Associate Professor, Ophthalmology
Contact us to find out if this trial is right for you.
Contact
Lisa Greer
650-725-9184
View on ClinicalTrials.gov
